Adial Pharmaceuticals Q1 EPS $(2.19) Misses $(0.35) Estimate
Adial Pharmaceuticals Q1 EPS $(2.19) Misses $(0.35) Estimate
Adial Pharmicals第一季度每股收益美元（2.19美元）未达到预期（0.35美元）
Adial Pharmaceuticals (NASDAQ:ADIL) reported quarterly losses of $(2.19) per share which missed the analyst consensus estimate of $(0.35) by 525.71 percent. This is a 20.36 percent increase over losses of $(2.75) per share from the same period last year.
Adial Pharmicals（纳斯达克股票代码：ADIL）公布的季度亏损为每股2.19美元，比分析师普遍预期的0.35美元（0.35美元）低525.71％。这比去年同期每股亏损2.75美元（2.75美元）增长了20.36％。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。